Therapeutic testing ina BM mouse model showed that HER3-targeted HBP with DOX payload impactedtumor proliferation, reduced tumor size, and prolonged overall survival.HER3-targeted HBP level detected in ex vivo brain samples was 14-foldmore than untargeted-HBP. This evidence concerns the gene ERBB3 and neoplasm.